SUDA Announces Strong Revenue For Westcoast
Filed with ASX · · 2 pages · English
Arovella Therapeutics Limited on 6ix
Story so far
Earlier from Arovella Therapeutics
- SUDA Update On Discussions with Berlin Pharma
- Reinstatement to official quotation
- Suspension from official quotation
- SUDA presents data on novel technology
- SUDA Enters Licensing Agreement For ZolpiMist in China
Later from Arovella Therapeutics
- SUDA expands patent coverage for SUD-003 and SUD-004
- SUDA Enters Feasibility Agreement With Pfizer
- SUDA Extends Maturity of Convertible Notes
- SUDA Submits Application For ArTiMist
- SUDA Completes $1.5m Capital Raising
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics